Free Trial
NASDAQ:ISRG

Intuitive Surgical Q3 2026 Earnings Date & Estimates

Intuitive Surgical logo
$427.64 +3.68 (+0.87%)
Closing price 10/12/2026 04:00 PM Eastern
Extended Trading
$427.04 -0.60 (-0.14%)
As of 10/12/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical is estimated to report Q3 2026 earnings on Tuesday, October 20, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET

What Analysts Expect from Intuitive Surgical in Q3 2026

Intuitive Surgical is expected to post earnings of $2.65 per share on revenue of $2.91 billion. In the same quarter a year earlier Intuitive Surgical reported $2.40 per share on revenue of $2.51 billion. Intuitive Surgical last reported on July 16, 2026, posting $2.80 per share and beating the $2.48 consensus estimate. Intuitive Surgical has beaten the consensus EPS estimate in 8 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$2.65
Expected Revenue
$2.91 billion
Prior-Year EPS
$2.40
Prior-Year Revenue
$2.51 billion
Expected EPS Growth
+10.4%
Expected Revenue Growth
+16.0%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$2.80 (Beat by +$0.32)
Last Quarter Revenue
$2.89 billion
EPS Beat Rate
8 of last 8 quarters

Intuitive Surgical Q3 2026 Earnings FAQ

Intuitive Surgical (NASDAQ:ISRG) is estimated to report Q3 2026 earnings on Tuesday, October 20, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Intuitive Surgical's Q3 2026 earnings conference call is scheduled for Tuesday, October 20, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Intuitive Surgical to post earnings of $2.65 per share for Q3 2026.

The consensus revenue estimate for Intuitive Surgical is $2.91 billion for Q3 2026.

Intuitive Surgical Earnings Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
Intuitive Surgical (NASDAQ:ISRG) Stock Price Target Lowered at BTIG Research
Intuitive Surgical (ISRG) Gets a Buy from Piper Sandler
See More Intuitive Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Intuitive Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intuitive Surgical and other key companies, straight to your email.

About Intuitive Surgical

Intuitive Surgical (NASDAQ:ISRG) develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures. Intuitive also offers the Ion endoluminal system for minimally invasive lung biopsy procedures, along with compatible instruments, accessories, digital technologies, training, and service programs.

Founded in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical serves hospitals and healthcare providers in the United States and international markets. The company’s systems are supported by recurring sales of instruments, accessories, and services. David J. Rosa serves as chief executive officer, following Gary S. Guthart, who led the company for many years.

View Intuitive Surgical Profile